Website
http://dataportal.arc.gov.au/NCGP/API/grants/LP0990788
Funding Status
Closed
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
Funded Activity Summary
Proteomic analysis of central nervous system inflammation in multiple sclerosis. This project aims to identify new therapeutic targets and diagnostics for Multiple Sclerosis (MS) the most common neurological disease in young adults. The estimated economic burden of this disease in Australia is around $2 billion per annum. There is also a large social cost to take into account. In spite of a great deal of research, current therapies are limited. We expect that this this research will: lead to new therapies and better diagnostics, which will reduce the financial and human cost of this disease; generate IP with subsequent economic benefits and; expand proteomics technologies which will have flow on effects including economic benefits and benefits to a wide range of basic research.Funded Activity Details
Start Date: 02-2010
End Date: 07-2012
Funding Scheme: Linkage Projects
Funding Amount: $375,000.00
Funder: Australian Research Council
Research Topics
ANZSRC Field of Research (FoR)
Central Nervous System | Biochemistry And Cell Biology Not Elsewhere Classified | Neurosciences | Biotechnology Not Elsewhere Classified
ANZSRC Socio-Economic Objective (SEO)
Nervous system and disorders | Treatments (e.g. chemicals, antibiotics) | Biological sciences |
